You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results
|
|---|---|
| Published in |
BMC Clinical Pharmacology, October 2009
|
| DOI | 10.1186/1472-6904-9-16 |
| Pubmed ID | |
| Authors |
James B Adams, Matthew Baral, Elizabeth Geis, Jessica Mitchell, Julie Ingram, Andrea Hensley, Irene Zappia, Sanford Newmark, Eva Gehn, Robert A Rubin, Ken Mitchell, Jeff Bradstreet, Jane El-Dahr |
| Abstract |
This study investigated the effect of oral dimercapto succinic acid (DMSA) therapy for children with autism spectrum disorders ages 3-8 years. |
X Demographics
The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 23% |
| United Kingdom | 2 | 5% |
| Canada | 1 | 2% |
| Burkina Faso | 1 | 2% |
| Jordan | 1 | 2% |
| Côte d'Ivoire | 1 | 2% |
| Poland | 1 | 2% |
| Italy | 1 | 2% |
| Ireland | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 24 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 38 | 88% |
| Scientists | 2 | 5% |
| Practitioners (doctors, other healthcare professionals) | 2 | 5% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Unknown | 81 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 15% |
| Student > Doctoral Student | 12 | 15% |
| Student > Master | 10 | 12% |
| Student > Bachelor | 9 | 11% |
| Other | 6 | 7% |
| Other | 19 | 23% |
| Unknown | 14 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 38% |
| Psychology | 7 | 9% |
| Agricultural and Biological Sciences | 6 | 7% |
| Neuroscience | 3 | 4% |
| Chemistry | 3 | 4% |
| Other | 12 | 15% |
| Unknown | 20 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 61. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2023.
All research outputs
#719,299
of 25,827,956 outputs
Outputs from BMC Clinical Pharmacology
#3
of 59 outputs
Outputs of similar age
#1,732
of 109,169 outputs
Outputs of similar age from BMC Clinical Pharmacology
#2
of 4 outputs
Altmetric has tracked 25,827,956 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 59 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,169 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.